StockIQ.techNeoGenomics, Inc. (NEO) Stock Analysis
Free AI-powered analysis and research for NeoGenomics, Inc. stock
Sector: Healthcare
Full NEO report
NeoGenomics, Inc. (NEO) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze NEO Now →📰 Latest Update
5 revealing analyst questions from NeoGenomics’s Q3 earnings call
Sat, October 31, 2026 at 7:47 PM UTC 4 min read
NeoGenomics reported an 11.4% year-over-year revenue increase in Q3, exceeding Wall Street expectations, driven by strong adoption of next-generation sequencing (NGS) tests and improved pricing strategies. CEO Anthony Zook noted a 29% growth in NGS revenue, while the company raised its full-year revenue and adjusted EPS guidance. Analysts raised questions during the earnings call regarding leadership transitions, sustainability of pricing growth, and strategies for expanding test adoption, highlighting key areas for future focus.